FDA Determines Regulatory Review Periods for Patent Extensions on Multiple Medical Devices, Pharmaceuticals
June 16, 2025
June 16, 2025
WASHINGTON, June 16 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has issued multiple notices determining the regulatory review periods for patent extension purposes for a series of medical devices and pharmaceutical products. These determinations, published as notices in the Federal Register on June 16, 2025, provide important information for patent holders seeking to extend patent terms based on the time consumed during the regulatory review process.< . . .